// App-Quantinova.ai

e18561 : Self-reported quality-of-life (QoL) impairment and productivity loss in patients with polycythemia vera (PV) enrolled in the REVEAL study.

Researchers

Presenter

  • Michael Richard Grunwald

Principal Investigators

  • Ralph V. Boccia

  • Alison Moliterno

  • Brady Stein

  • Stephen T. Oh

  • Ahmad Bilal Naim

  • Joseph A. Cordaro

  • Wei Peng

  • Hao Sun

  • Shreekant Parasuraman

  • Ruben A. Mesa

Medical Centers

  • Levine Cancer Institute, Charlotte, SC

  • Center for Cancer and Blood Disorders, Bethesda, MD

  • Johns Hopkins University, Baltimore, MD

  • Northwestern University, Feinberg School of Medicine, Chicago, IL

  • Washington University, St Louis, MO

  • Incyte Corporation, Wilmington, DE

  • Mayo Clinic, Scottsdale, AZ

Locations

  • United States

Companies

  • Incyte Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myeloid neoplasms

  • Polycythemia vera

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • Observational

  • Prospective

Phase

  • NA

Study Id's

  • NCT02252159

Sponsors

  • N/A

Result

  • Final